Paper23935944
O-GlcNAcylation-inducing treatments inhibit estrogen receptor α expression and confer resistance to 4-OH-tamoxifen in human breast cancer-derived MCF-7 cells.
Kanwal S and 7 others. PLoS One, 2013. Cited by 60 papers, by iCite.
Cite this record
ConductScience Library. O-GlcNAcylation-inducing treatments inhibit estrogen receptor α expression and confer resistance to 4-OH-tamoxifen in human breast cancer-derived MCF-7 cells. Papers, record 23935944. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/23935944
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- O-GlcNAcylation-inducing treatments inhibit estrogen receptor α expression and confer resistance to 4-OH-tamoxifen in human breast cancer-derived MCF-7 cells.
- PubMed
Topics22
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Breast Neoplasms | Major topic |
| Drug Resistance, Neoplasm | Major topic |
| Estrogen Receptor alpha | Major topic |
| Gene Expression Regulation, Neoplastic | Major topic |
| Protein Processing, Post-Translational | Major topic |
| Selective Estrogen Receptor Modulators | Major topic |
| Tamoxifen | Major topic |
| Acetylglucosamine | |
| Antineoplastic Agents, Hormonal | |
| Biosynthetic Pathways | |
| Cell Death | |
| Female | |
| Hexosamines | |
| Humans | |
| Insulin-Like Growth Factor I | |
| MCF-7 Cells | |
| Oximes | |
| Phenylcarbamates | |
| Phosphatidylinositol 3-Kinases | |
| Promoter Regions, Genetic | |
| Proto-Oncogene Proteins c-akt | |
| Signal Transduction |
Source PubMed
References64
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 22275356 | Critical role of O-Linked β-N-acetylglucosamine transferase in prostate cancer invasion, angiogenesis, and metastasis. | J Biol Chem | 2012 | https://conductscience.org/library/papers/22275356 | PubMed |
| 2 | 7448733 | The value of estrogen and progesterone receptors in the treatment of breast cancer. | Cancer | 1980 | https://conductscience.org/library/papers/7448733 | PubMed |
| 3 | 19935718 | c-Jun activation is required for 4-hydroxytamoxifen-induced cell death in breast cancer cells. | Oncogene | 2010 | https://conductscience.org/library/papers/19935718 | PubMed |
| 4 | 15999367 | Early growth response gene 1 (EGR1) is deleted in estrogen receptor-negative human breast carcinoma. | Cancer | 2005 | https://conductscience.org/library/papers/15999367 | PubMed |
| 5 | 9851716 | Fibroblast growth factor-2 has opposite effects on human breast cancer MCF-7 cell growth depending on the activation level of the mitogen-activated protein kinase pathway. | Eur J Biochem | 1998 | https://conductscience.org/library/papers/9851716 | PubMed |
| 6 | 18928543 | A candidate molecular signature associated with tamoxifen failure in primary breast cancer. | Breast Cancer Res | 2008 | https://conductscience.org/library/papers/18928543 | PubMed |
| 7 | 18288188 | Phosphoinositide signalling links O-GlcNAc transferase to insulin resistance. | Nature | 2008 | https://conductscience.org/library/papers/18288188 | PubMed |
| 8 | 20699577 | Elevated O-linked N-acetylglucosamine correlated with reduced Sp1 cooperative DNA binding with its collaborating factors in vivo. | Biosci Biotechnol Biochem | 2010 | https://conductscience.org/library/papers/20699577 | PubMed |
| 9 | 2766299 | Up-regulation of estrogen receptors by nonsteroidal antiestrogens in human breast cancer. | Cancer Res | 1989 | https://conductscience.org/library/papers/2766299 | PubMed |
| 10 | 9259322 | Human estrogen receptor (ER) gene promoter-P1: estradiol-independent activity and estradiol inducibility in ER+ and ER- cells. | Mol Endocrinol | 1997 | https://conductscience.org/library/papers/9259322 | PubMed |
| 11 | 20190804 | Nutrient sensor O-GlcNAc transferase regulates breast cancer tumorigenesis through targeting of the oncogenic transcription factor FoxM1. | Oncogene | 2010 | https://conductscience.org/library/papers/20190804 | PubMed |
| 12 | 21487008 | A new highly efficient substrate-trapping mutant of protein tyrosine phosphatase 1B (PTP1B) reveals full autoactivation of the insulin receptor precursor. | J Biol Chem | 2011 | https://conductscience.org/library/papers/21487008 | PubMed |
| 13 | 16598783 | Post-translational modification by O-GlcNAc: another way to change protein function. | J Cell Biochem | 2006 | https://conductscience.org/library/papers/16598783 | PubMed |
| 14 | 7753821 | Glycosylation of the c-Myc transactivation domain. | Proc Natl Acad Sci U S A | 1995 | https://conductscience.org/library/papers/7753821 | PubMed |
| 15 | 19635455 | Implication of protein tyrosine phosphatase 1B in MCF-7 cell proliferation and resistance to 4-OH tamoxifen. | Biochem Biophys Res Commun | 2009 | https://conductscience.org/library/papers/19635455 | PubMed |
| 16 | 22848683 | Effect of insulin analogues on insulin/IGF1 hybrid receptors: increased activation by glargine but not by its metabolites M1 and M2. | PLoS One | 2012 | https://conductscience.org/library/papers/22848683 | PubMed |
| 17 | 18359296 | O-GlcNAc modification of FoxO1 increases its transcriptional activity: a role in the glucotoxicity phenomenon? | Biochimie | 2008 | https://conductscience.org/library/papers/18359296 | PubMed |
| 18 | 3345786 | Receptor levels in breast cancer. | Eur J Gynaecol Oncol | 1988 | https://conductscience.org/library/papers/3345786 | PubMed |
| 19 | 10908655 | Down-regulation of p21WAF1/CIP1 or p27Kip1 abrogates antiestrogen-mediated cell cycle arrest in human breast cancer cells. | Proc Natl Acad Sci U S A | 2000 | https://conductscience.org/library/papers/10908655 | PubMed |
| 20 | 17307334 | Tamoxifen-induced activation of p21Waf1/Cip1 gene transcription is mediated by Early Growth Response-1 protein through the JNK and p38 MAP kinase/Elk-1 cascades in MDA-MB-361 breast carcinoma cells. | Cell Signal | 2007 | https://conductscience.org/library/papers/17307334 | PubMed |
Cited by37
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 60 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40574323 | Protein O-GlcNAcylation in reproductive biology and the impact of metabolic disease. | Hum Reprod Update | 2025 | https://conductscience.org/library/papers/40574323 | PubMed |
| 39967646 | Clozapine as an E3 Ligand for PROTAC Technology. | ACS Med Chem Lett | 2025 | https://conductscience.org/library/papers/39967646 | PubMed |
| 38715825 | Comparative metabolomics of MCF-7 and MCF-7/TAMR identifies potential metabolic pathways in tamoxifen resistant breast cancer cells. | Am J Transl Res | 2024 | https://conductscience.org/library/papers/38715825 | PubMed |
| 37528140 | TRIM28 modulates nuclear receptor signaling to regulate uterine function. | Nat Commun | 2023 | https://conductscience.org/library/papers/37528140 | PubMed |
| 36359776 | Drug Resistance in Cancers: A Free Pass for Bullying. | Cells | 2022 | https://conductscience.org/library/papers/36359776 | PubMed |
| 36059648 | Targeting O-GlcNAcylation to overcome resistance to anti-cancer therapies. | Front Oncol | 2022 | https://conductscience.org/library/papers/36059648 | PubMed |
| 35296731 | Increased O-GlcNAcylation promotes IGF-1 receptor/PhosphatidyI Inositol-3 kinase/Akt pathway in cervical cancer cells. | Sci Rep | 2022 | https://conductscience.org/library/papers/35296731 | PubMed |
| 35216622 | Unconventional protein post-translational modifications: the helmsmen in breast cancer. | Cell Biosci | 2022 | https://conductscience.org/library/papers/35216622 | PubMed |
| 34845374 | Thymidylate synthase O-GlcNAcylation: a molecular mechanism of 5-FU sensitization in colorectal cancer. | Oncogene | 2022 | https://conductscience.org/library/papers/34845374 | PubMed |
| 34441396 | Prognostic Significance of O-GlcNAc and PKM2 in Hormone Receptor-Positive and HER2-Nonenriched Breast Cancer. | Diagnostics (Basel) | 2021 | https://conductscience.org/library/papers/34441396 | PubMed |
| 33731348 | GREB1: An evolutionarily conserved protein with a glycosyltransferase domain links ERα glycosylation and stability to cancer. | Sci Adv | 2021 | https://conductscience.org/library/papers/33731348 | PubMed |
| 33550377 | Evidence and manipulation of O-GlcNAcylation in granulosa cells of bovine antral follicles†. | Biol Reprod | 2021 | https://conductscience.org/library/papers/33550377 | PubMed |
| 31883602 | Recent advances in cancer chemoprevention with phytochemicals. | J Food Drug Anal | 2020 | https://conductscience.org/library/papers/31883602 | PubMed |
| 31466420 | Hyperglycemia-Induced Aberrant Cell Proliferation; A Metabolic Challenge Mediated by Protein O-GlcNAc Modification. | Cells | 2019 | https://conductscience.org/library/papers/31466420 | PubMed |
| 31272438 | Fueling the fire: emerging role of the hexosamine biosynthetic pathway in cancer. | BMC Biol | 2019 | https://conductscience.org/library/papers/31272438 | PubMed |
| 30952976 | O-GlcNAc Transferase Inhibition Differentially Affects Breast Cancer Subtypes. | Sci Rep | 2019 | https://conductscience.org/library/papers/30952976 | PubMed |
| 30626734 | Nutrient regulation of signaling and transcription. | J Biol Chem | 2019 | https://conductscience.org/library/papers/30626734 | PubMed |
| 30420690 | O-GlcNAcylation of GLI transcription factors in hyperglycemic conditions augments Hedgehog activity. | Lab Invest | 2019 | https://conductscience.org/library/papers/30420690 | PubMed |
| 30375428 | A novel somatic mutation of SIN3A detected in breast cancer by whole-exome sequencing enhances cell proliferation through ERα expression. | Sci Rep | 2018 | https://conductscience.org/library/papers/30375428 | PubMed |
| 30356686 | Cross-Dysregulation of O-GlcNAcylation and PI3K/AKT/mTOR Axis in Human Chronic Diseases. | Front Endocrinol (Lausanne) | 2018 | https://conductscience.org/library/papers/30356686 | PubMed |
Genes15
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/23935944
GET https://conductscience.org/api/papers/v1/23935944/references?page=2